SNTI Senti Biosciences Holdings, Inc.

-

Senti Biosciences Missed Consensus Estimates

Friday, August 14, 2026 · 12:00 AM ET

Senti Biosciences (SNTI) reported a loss of $0.41 per share on revenue of $0.02 million for the second quarter ended June 2026. The consensus estimate was a loss of $0.33 per share on revenue of $0.10 million. The company missed consensus estimates by 24.24%.

Senti Biosciences Inc. is a biotechnology company developing next-generation cell and gene therapies using its proprietary gene circuit platform. Senti Biosciences Inc., formerly known as Dynamics Special Purpose Corp., is based in SOUTH SAN FRANCISCO, Calif.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.41)
Earnings Whisper®
Consensus Estimate
($0.33)
Earnings Surprise
Earnings Growth26.8 %
Reported Revenue
$0.02M
Revenue Estimate
$0.10M
Revenue Surprise
Revenue Growth